540701 Stock Overview
Provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Dishman Carbogen Amcis Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹241.80 |
52 Week High | ₹282.95 |
52 Week Low | ₹132.75 |
Beta | 1.24 |
11 Month Change | 25.38% |
3 Month Change | 23.37% |
1 Year Change | 47.75% |
33 Year Change | -1.12% |
5 Year Change | 94.76% |
Change since IPO | -31.16% |
Recent News & Updates
Recent updates
Shareholder Returns
540701 | IN Life Sciences | IN Market | |
---|---|---|---|
7D | 4.3% | 2.5% | 2.0% |
1Y | 47.8% | 55.7% | 26.6% |
Return vs Industry: 540701 underperformed the Indian Life Sciences industry which returned 53.9% over the past year.
Return vs Market: 540701 exceeded the Indian Market which returned 27.9% over the past year.
Price Volatility
540701 volatility | |
---|---|
540701 Average Weekly Movement | 8.7% |
Life Sciences Industry Average Movement | 6.6% |
Market Average Movement | 6.1% |
10% most volatile stocks in IN Market | 9.1% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 540701's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 540701's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | 1,132 | Arpit Vyas | imdcal.com |
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutical and cosmetic-related products; vitamin D products and its analogues; hand and body wash, sanitizers, and antiseptics; and phase transfer catalysts, soft gel capsules, disinfectant formulations, cholesterol, lanolin-related products, and liquid and lyophilized sterile injectables.
Dishman Carbogen Amcis Limited Fundamentals Summary
540701 fundamental statistics | |
---|---|
Market cap | ₹37.86b |
Earnings (TTM) | -₹1.74b |
Revenue (TTM) | ₹26.19b |
1.4x
P/S Ratio-21.8x
P/E RatioIs 540701 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
540701 income statement (TTM) | |
---|---|
Revenue | ₹26.19b |
Cost of Revenue | ₹7.25b |
Gross Profit | ₹18.93b |
Other Expenses | ₹20.68b |
Earnings | -₹1.74b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -11.10 |
Gross Margin | 72.31% |
Net Profit Margin | -6.65% |
Debt/Equity Ratio | 37.7% |
How did 540701 perform over the long term?
See historical performance and comparison